ChemoCentryx (CCXI) PT Raised to $64 at Raymond James
Tweet
Share
E-mailGet Alerts CCXI Hot Sheet
Price: $13.82 +4.22%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Raymond James analyst Steven Seedhouse raised the price target on ChemoCentryx (NASDAQ: CCXI) to $64.00 (from $56.00) while maintaining a Strong Buy rating.
You May Also Be Interested In
- Goldman Sachs Downgrades Telenor ASA (TEL:NO) (TELNY) to Neutral
- Goldman Sachs Downgrades Elisa Oyj (ELISA:FH) (ELMUY) to Neutral
- The Campbell's Co. (CPB) PT Lowered to $20 at Jefferies, 'we remain cautious'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
